AIP Arteris, Inc.
Semiconductors & Related Devices · Nasdaq · SEC CIK 1667011 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY41.0%
TTM net income YoY-21.0%
TTM EPS YoY-7.2%
Revenue 3-yr CAGR21.1%
Net income 3-yr CAGR—
Margins
Gross margin86.9%
Operating margin-46.2%
Net margin-44.8%
FCF margin2.3%
EBITDA margin-40.7%
Returns
ROE-153.2%
ROA-24.8%
ROIC (approx.)—
Asset turnover0.55x
Leverage & solvency
Liabilities / assets71.1%
Debt / equity0.00x
Current ratio1.35x
Interest coverage-207.69x
Cash quality & payout
Operating cash flow / net income-0.09x
Accruals ratio-27.0%
Payout ratio—
Capex / revenue1.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $70.58M | $57.72M |
| Cost of revenue | $6.89M | $5.96M |
| Gross profit | $63.68M | $51.76M |
| R&D expense | $49.91M | $45.01M |
| SG&A expense | $20.13M | $17.55M |
| Operating income | -$33.14M | -$31.60M |
| Interest expense | $193,000 | $244,000 |
| Pretax income | -$33.27M | -$31.14M |
| Income tax | $1.48M | $2.50M |
| Net income | -$34.75M | -$33.64M |
| EBITDA | -$29.76M | -$28.23M |
| EPS (basic) | -0.82 | -0.86 |
| EPS (diluted) | -0.82 | -0.86 |
| Weighted avg. shares (diluted) | 42.29M | 38.91M |
| Balance sheet | ||
| Cash & equivalents | $33.90M | $14.07M |
| Short-term investments | — | $30.16M |
| Receivables | $19.18M | $20.61M |
| Current assets | $82.39M | $69.08M |
| PP&E, net | $3.87M | $4.02M |
| Goodwill | $4.18M | $4.18M |
| Intangibles | $2.17M | $3.02M |
| Total assets | $115.03M | $106.14M |
| Current liabilities | $73.20M | $59.28M |
| Total liabilities | $129.66M | $107.32M |
| Shareholders' equity | -$14.63M | -$1.19M |
| Shares outstanding | 44.27M | 40.72M |
| Cash flow statement | ||
| Operating cash flow | $6.73M | -$720,000 |
| Capital expenditure | $1.39M | $324,000 |
| Free cash flow | $5.34M | -$1.04M |
| Investing cash flow | $12.03M | $970,000 |
| Financing cash flow | $1.42M | -$262,000 |
| Depreciation & amortization | $3.38M | $3.36M |
| Stock-based compensation | $18.38M | $15.94M |
Free plan shows the latest 2 periods; Pro shows all 6 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.